Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$224.58 - $256.19 $372,802 - $425,275
-1,660 Reduced 15.3%
9,187 $2.29 Million
Q4 2023

Jan 18, 2024

SELL
$185.1 - $233.13 $360,019 - $453,437
-1,945 Reduced 15.2%
10,847 $2.51 Million
Q3 2023

Oct 16, 2023

SELL
$233.08 - $265.59 $493,896 - $562,785
-2,119 Reduced 14.21%
12,792 $3.17 Million
Q2 2023

Jul 28, 2023

SELL
$224.99 - $256.14 $479,453 - $545,834
-2,131 Reduced 12.5%
14,911 $3.58 Million
Q1 2023

Apr 21, 2023

SELL
$239.75 - $277.0 $13,426 - $15,512
-56 Reduced 0.33%
17,042 $4.3 Million
Q4 2022

Jan 27, 2023

BUY
$241.42 - $282.29 $44,904 - $52,505
186 Added 1.1%
17,098 $0
Q3 2022

Nov 15, 2022

BUY
$247.06 - $1507.4 $4.18 Million - $25.5 Million
16,912 New
16,912 $4.37 Million
Q2 2022

Jul 28, 2022

SELL
$237.11 - $299.66 $480,147 - $606,811
-2,025 Reduced 10.46%
17,328 $4.39 Million
Q1 2022

Apr 13, 2022

SELL
$257.27 - $315.76 $558,790 - $685,830
-2,172 Reduced 10.09%
19,353 $5.68 Million
Q4 2021

Feb 01, 2022

SELL
$292.08 - $329.01 $176,124 - $198,393
-603 Reduced 2.73%
21,525 $7.08 Million
Q3 2021

Oct 25, 2021

SELL
$272.21 - $332.43 $162,781 - $198,793
-598 Reduced 2.63%
22,128 $6.74 Million
Q2 2021

Jul 21, 2021

BUY
$225.08 - $271.69 $42,540 - $51,349
189 Added 0.84%
22,726 $6.23 Million
Q1 2021

May 04, 2021

BUY
$212.38 - $245.9 $56,493 - $65,409
266 Added 1.19%
22,537 $5.07 Million
Q4 2020

Jan 14, 2021

BUY
$212.5 - $245.46 $1.62 Million - $1.87 Million
7,637 Added 52.19%
22,271 $4.95 Million
Q3 2020

Oct 26, 2020

BUY
$177.16 - $215.33 $616,693 - $749,563
3,481 Added 31.21%
14,634 $3.4 Million
Q2 2020

Aug 10, 2020

BUY
$128.7 - $176.83 $332,045 - $456,221
2,580 Added 30.09%
11,153 $1.97 Million
Q1 2020

Apr 29, 2020

BUY
$121.39 - $169.05 $1.04 Million - $1.45 Million
8,573 New
8,573 $1.19 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Traynor Capital Management, Inc. Portfolio

Follow Traynor Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.